Showing 76–100 of 7,717 international scientific journals
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 76 | Utilities Policy ISSN: 0957-1787 | 🇬🇧United Kingdom | Q3 | CAS Tier 2 | 4.9 | 1.073Q1 | 42 | 130 | 13.2% | Elsevier BV | Profile |
| 77 | World Journal of Stem Cells ISSN: 1948-0210 | 🇺🇸United States | Q2 | CAS Tier 3 | 4.9 | 0.884Q2 | 1 | 109 | 2.8% | Baishideng Publishing Group | Profile |
| 78 | ACS Physical Chemistry Au ISSN: 2694-2445 | 🇺🇸United States | Q2 | CAS Tier 2 | 4.8 | 1.041Q1 | — | — | 0% | American Chemical Society | Profile |
| 79 | Advanced Nanobiomed Research ISSN: 2699-9307 | 🇩🇪Germany | Q2 | CAS Tier 4 | 4.8 | 1.058Q1 | — | 55 | 2.5% | Wiley-VCH, Germany | Profile |
| 80 | Antibody Therapeutics ISSN: 2516-4236 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 4.8 | 1.003Q2 | — | 46 | N/A | Oxford University Press | Profile |
| 81 | Energy Conversion and Economics ISSN: 2634-1581 | 🇬🇧United Kingdom | Q3 | — | 4.8 | — | — | 23 | N/A | Wiley | Profile |
| 82 | Geomechanics for Energy and the Environment ISSN: 2352-3808 | 🇳🇱Netherlands | Q3 | CAS Tier 2 | 4.8 | 1.075Q1 | — | 45 | 15.2% | Elsevier BV | Profile |
| 83 | Harvard Data Science Review ISSN: 2644-2353 | 🌐International | Q2 | CAS Tier 4 | 4.8 | — | — | — | N/A | Updating | Profile |
| 84 | International Journal of Intelligent Systems ISSN: 0884-8173 / 1098-111XTop Tier | 🇺🇸United States | Q2 | CAS Tier 3 | 4.8 | 0.903Q1 | 72 | 425 | 4% | John Wiley and Sons Ltd | Profile |
| 85 | Revista Espanola De Enfermedades Digestivas ISSN: 1130-0108Diamond OA | 🌐Spain | Q1 | CAS Tier 4 | 4.8 | 0.267Q3 Diamond OA | 34 | 99 | 29.6% | ARAN Ediciones S.A. | Profile |
| 86 | Solar RRL ISSN: 2367-198X | 🇩🇪Germany | Q3 | CAS Tier 3 | 4.8 | 1.161Q1 | — | 477 | 6.7% | Wiley-Blackwell | Profile |
| 87 | Discover Environment ISSN: 2731-9431 | 🌐International | Q2 | — | 4.7 | 0.735Q1 | — | — | N/A | Updating | Profile |
| 88 | Drug Metabolism Reviews ISSN: 0360-2532 / 1097-9883Top Tier | 🇺🇸United States | Q1 | CAS Tier 3 | 4.7 | 0.93Q1 | 89 | 24 | 2.9% | Informa Healthcare | Profile |
| 89 | Expert Opinion on Therapeutic Patents ISSN: 1354-3776 / 1744-7674Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 4.7 | 1.098Q1 | 61 | 66 | 1.9% | Taylor and Francis Ltd. | Profile |
| 90 | Frontiers in Environmental Chemistry ISSN: 2673-4486 | 🇨🇭Switzerland | Q3 | CAS Tier 4 | 4.7 | 0.916Q1 | — | 14 | N/A | Frontiers Media S.A. | Profile |
| 91 | Geothermal Energy ISSN: 2195-9706 | 🇺🇸United States | Q3 | CAS Tier 3 | 4.7 | 1.008Q1 | — | 26 | 6.9% | Springer Berlin Heidelberg | Profile |
| 92 | Molecular and Cellular Biochemistry ISSN: 0300-8177 / 1573-4919 | 🇳🇱Netherlands | Q2 | CAS Tier 2 | 4.7 | 1.174Q1 | 115 | 299 | 0% | Springer US | Profile |
| 93 | Next Materials ISSN: 2949-8228 | 🌐International | Q2 | — | 4.7 | 0.776Q1 | — | — | N/A | Updating | Profile |
| 94 | Synthetic Biology ISSN: 1939-7267 / 2397-7000 | 🇬🇧United Kingdom | Q1 | CAS Tier 3 | 4.7 | 0.946Q1 | — | 28 | 7.7% | Oxford University Press | Profile |
| 95 | Current Clinical Microbiology Reports ISSN: 2196-5471Top Tier | 🌐International | Q2 | CAS Tier 3 | 4.6 | 1.128Q1 | — | 20 | 0% | Springer Nature | Profile |
| 96 | Epilepsy Currents ISSN: 1535-7597 / 1535-7511Top Tier | 🇺🇸United States | Q1 | CAS Tier 2 | 4.6 | 0.295Q3 | 18 | 44 | 17.2% | American Epilepsy Society | Profile |
| 97 | Evolutionary Intelligence ISSN: 1864-5909 / 1864-5917 | 🇩🇪Germany | Q2 | CAS Tier 4 | 4.6 | 0.7Q1 | — | 195 | 0% | Springer Nature | Profile |
| 98 | Expert Review of Anti-Infective Therapy ISSN: 1478-7210 / 1744-8336Top Tier | 🇬🇧United Kingdom | Q1 | CAS Tier 3 | 4.6 | 1.024Q1 | 65 | 116 | 2.4% | Taylor and Francis Ltd. | Profile |
| 99 | Frontiers in Medical Technology ISSN: 2673-3129 | 🇨🇭Switzerland | Q2 | CAS Tier 3 | 4.6 | 0.91Q1 | — | 91 | 0% | Frontiers Media S.A. | Profile |
| 100 | Geothermics ISSN: 0375-6505 | 🇬🇧United Kingdom | Q3 | CAS Tier 2 | 4.6 | 1.102Q1 | 58 | 279 | 11.4% | Elsevier Ltd | Profile |